| Nanoscale imaging of clinical specimens using pathology-optimized expansion microscopy Y Zhao, O Bucur, H Irshad, F Chen, A Weins, AL Stancu, EY Oh, ... Nature biotechnology 35 (8), 757-764, 2017 | 197 | 2017 |
| Targeted therapies for advanced non-small cell lung cancer X Ai, X Guo, J Wang, AL Stancu, PMN Joslin, D Zhang, S Zhu Oncotarget 9 (101), 37589, 2018 | 65 | 2018 |
| PAM50 molecular intrinsic subtypes in the Nurses' health study cohorts KH Kensler, VN Sankar, J Wang, X Zhang, CA Rubadue, GM Baker, ... Cancer Epidemiology, Biomarkers & Prevention 28 (4), 798-806, 2019 | 29 | 2019 |
| Combination of bortezomib and mitotic inhibitors down-modulate Bcr-Abl and efficiently eliminates tyrosine-kinase inhibitor sensitive and resistant Bcr-Abl-positive leukemic cells O Bucur, AL Stancu, I Goganau, SM Petrescu, B Pennarun, T Bertomeu, ... PLoS One 8 (10), e77390, 2013 | 26 | 2013 |
| PLK1 is a binding partner and a negative regulator of FOXO3 tumor suppressor O Bucur, AL Stancu, MS Muraru, A Melet, SM Petrescu, R Khosravi-Far Discoveries 2 (2), 2014 | 23 | 2014 |
| Analysis of apoptosis methods recently used in Cancer Research and Cell Death & Disease publications O Bucur, AL Stancu, R Khosravi-Far, A Almasan Cell death & disease 3 (2), e263-e263, 2012 | 19 | 2012 |
| AMPK activation can delay aging AL Stancu Discoveries 3 (4), 2015 | 17 | 2015 |
| Poor antibody validation is a challenge in biomedical research: a case study for detection of c-FLIP O Bucur, B Pennarun, AL Stancu, M Nadler, MS Muraru, T Bertomeu, ... Apoptosis 18, 1154-1162, 2013 | 17 | 2013 |
| Deep learning image analysis of benign breast disease to identify subsequent risk of breast cancer AD Vellal, K Sirinukunwattan, KH Kensler, GM Baker, AL Stancu, ME Pyle, ... JNCI Cancer Spectrum 5 (1), pkaa119, 2021 | 11 | 2021 |
| Thyroid-related adverse events induced by immune checkpoint inhibitors A Chera, AL Stancu, O Bucur Frontiers in Endocrinology, 2277, 2022 | 6 | 2022 |
| Gut microbiome and the response to immunotherapy in cancer AL Stancu Discoveries 6 (3), 2018 | 6 | 2018 |
| Developing a Deep Learning Image Analysis Pipeline for Benign Breast Disease YJ Heng, AD Vellal, K Sirinukunwattana, G Baker, A Stancu, M Pyle, ... LABORATORY INVESTIGATION 98, 589-589, 2018 | 2 | 2018 |
| New agents for the treatment of lymphoid leukemia and lymphoma: focus on recent FDA approvals AL Stancu, MR Smith, A Almasan Discoveries 2 (1), 2014 | 2 | 2014 |
| Discoveries: an innovative platform for publishing cutting-edge research discoveries in medicine, biology and chemistry O Bucur, A Almasan, BS Nikolajczyk, GL Nicolson, J Lawler, ... Discoveries 1 (1), 2013 | 2 | 2013 |
| Quantifying chromosomal copy number alterations in breast ductal carcinoma in situ: a deep learning based approach K Sirinukunwattana, J Lin, P Lu, F Beca, J Peng, A Tolwani, A Stancu, ... 2018 IEEE 15th International Symposium on Biomedical Imaging (ISBI 2018 …, 2018 | 1 | 2018 |
| Monkeypox: a global health emergency RI Stilpeanu, AM Stercu, AL Stancu, A Tanca, O Bucur Frontiers in Microbiology 14, 1094794, 2023 | | 2023 |
| Understanding Clinical Responses to Immune Checkpoint Therapies Using a Novel Neoantigen-Rich Murine Melanoma Cell Model A Stancu, L Prestegarden, H Widlund LABORATORY INVESTIGATION 100 (SUPPL 1), 499-500, 2020 | | 2020 |
| PI3K Inhibitors for Breast Cancer: First FDA Approved Regimen AL Stancu Discoveries 7 (4), e103, 2019 | | 2019 |
| Distribution of PAM50 Intrinsic Subtypes in Primary Invasive Breast Cancer and Morphologically Normal Tumor-Adjacent Epithelium: Report from the Nurses' Health Study C Rubadue, G Baker, J Wang, X Zhang, K Kensler, A Stancu, M Pyle, ... LABORATORY INVESTIGATION 98, 102-102, 2018 | | 2018 |
| Expansion Pathology Enables Super-Resolution Optical Investigation of Proteins for Diagnostic Pathology and Research O Bucur, Y Zhao, H Irshad, A Stancu, A Weins, S Schnitt, M Pollak, ... PROTEIN SCIENCE 26, 164-164, 2017 | | 2017 |
